SCHEMBL29310725

SCHEMBL29310725

CC1(C)c2ccccc2-c2ccc(N(c3ccc(-c4ccc5c(c4)oc4ccccc45)cc3)c3ccc4c(c3)C(c3ccccc3)(c3ccccc3)c3ccccc3-4)cc21

nearest known ligand 0.33

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
MMP12 P39900 1/20 0.33
MMP13 P45452 1/20 0.33
HCRTR1 O43613 1/20 0.31
ALK Q9UM73 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9916350 1.00 MMP12 (0.33) MMP12MMP13HCRTR1ALK
SCHEMBL21559474 0.98 MMP12 (0.32) MMP12MMP13HCRTR1ALK
SCHEMBL25814656 0.96 MMP12 (0.32) MMP12MMP13HCRTR1ALK
SCHEMBL21923911 0.95
SCHEMBL29310743 0.94 HCRTR1 (0.32) MMP12MMP13HCRTR1ALK
SCHEMBL18118701 0.94 ESR1 (0.31) ALK
SCHEMBL9916308 0.94 HSP90AA1 (0.33) ALK
SCHEMBL16996001 0.94 HSP90AA1 (0.33) ALK
SCHEMBL29310728 0.94 HCRTR1 (0.33) MMP12MMP13HCRTR1ALK
SCHEMBL21923914 0.93 PDK2 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240237513-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC APPLIANCE IDEMITSU KOSAN CO., LTD. (JP) 2024-07-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240237513-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC APPLIANCE EED, PIEZO1, OLA1 MMP12 1208/4885MMP13 3162/4885HCRTR1 2472/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.